Follow us...

 

Search News Archives

News Channels

 

New Laboratory Products

Lab News

Research & Case Studies

Microscopy | Image Analysis

Separation Science

Brochures & Literature

Videos

Events | Webinars

 

 

Conferences | Events
Sphere Fluidics Limited

Sphere Fluidics Limited

Sphere Fluidics Limited

Products

Contact Sphere Fluidics Limited


If you have not logged into the website then please enter your details below.

All articles from Sphere Fluidics Limited

  Sphere Fluidics and Peak Analysis and Automation introduce integrated micro-plate handling and single cell analysis capabilities

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leading supplier of intelligent laboratory automation solutions, have announced the optimization of the Cyto-Mine® Single Cell Analysis System through integration with PAA’s automated plate handler, S-LAB™. The addition of S-LAB to the Cyto-Mine provides researchers with a further streamlined solution for single cell analysis...

 

  Sphere Fluidics introduces Cyto-Cellect Human IgGK Detection Kit

The Cyto-Cellect Human IgGK Detection Kit has been developed to provide Cyto-Mine users with an easy-to-use, standardized assay format for the detection of secreted human antibodies in picodroplets. The sensitive FRET-based assay rapidly detects the presence of human IgG with kappa light chain after secretion from encapsulated cells, to characterize and measure antibody production....

 

  Sphere Fluidics introduces latest version of Cyto-Mine Studio Software Suite

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has introduced an updated version of its Cyto-Mine® Studio Software Suite, a collection of software controlling operation of its Cyto-Mine Single Cell Analysis System, data acquisition and follow-up analysis....

 

  Sphere Fluidics expands into additional facility at Granta Park in Cambridge, UK

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has announced that it has opened a new office space at Granta Park in Cambridgeshire, UK. The new facilities support the Company’s accelerated expansion and accommodate its plans for further growth....

 

  Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

sphere fluidicsSphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announce that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine ®Single Cell Analysis System, expansion of the UK facility and enable....

 

  Sphere Fluidics Closes $2 Million USD (c. £1.5 million GBP) Investment Round

sphere fluidicsInvestment received from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket. Funding will be used to accelerate growth in operations and sales across the UK and USA. Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that is has closed a $2 million (circa£1.5 million) investment round...

 

  Sphere Fluidics collaborates with Peak Analysis and Automation to increase throughput in antibody discovery and cell line development

Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leader in the industry for the design and manufacture of automated laboratory equipment, will collaborate to offer automated micro-plate handling capabilities for single cell analysis. PAA's S-LAB™ plate handler will be integrated with Sphere Fluidics’ Cyto-Mine® Single Cell Analysis System...

 

  Sphere Fluidics Introduces new Cyto-Mine Studio Software Suite

Cyto-MineSphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today introduced Cyto-Mine® Studio Software Suite, an updated software for its innovative Cyto-Mine Single Cell Analysis System. The software works alongside industry-standard robotic platforms and corporate databases to improve antibody discovery and cell line development workflows...

 

  Sphere Fluidics Appoints Dr Tris Vaughan as Scientific Advisor

Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, has announced that Tris Vaughan, PhD FRSB has joined its scientific advisory board (SAB). Dr Vaughan’s appointment will further strengthen the company’s understanding of biopharmaceutical discovery and cell line development and help translate its technology to an industrial context...

 

  Sphere Fluidics and Geneva Biotech Receive Eurostars Genome Editing Grant

€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project

SphereSphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a €1.6 million grant from Eurostars....

 

 

Promotions

 

Media Partners